Bill has been an accomplished patent attorney amassing a tremendous amount of experience in the legal biotech and pharma space. He has secured and defended world-wide patent protection for chemical, biotechnology and device inventions, litigation of chemical, biotechnology and device patents in the US and globally (including Hatch-Waxman litigations in the US, and PMNOC litigations in Canada). Mr. Coppola holds a J.D. from Seton Hall University School of Law. He received a graduate degree in Biochemistry from the University of South Florida, and an undergraduate degree in Chemistry from the University of Delaware. He is a registered patent attorney who is admitted to practice law in New Jersey, New York, Florida, and the District of Columbia. He is also a member of the Phi Kappa Phi Honor society and an Eagle Scout.
While the EU passed its AI Act in March 2024, the US has experienced somewhat of a complicated start regarding regulation on AI. With President Biden’s Executive Order in October 2023 and Colorado’s first in the nation AI law in May 2024, as well as the USPTO and FDA releasing their own guidance about the use of AI, the regulatory landscape is blurry for companies who are eager to trial but worried about compliance and ethics without the necessary laws to follow. The question, then, becomes how companies can push ahead with innovation and documentation whilst remaining compliant, ethical and respectful of customer and employee data.
Check out the incredible speaker line-up to see who will be joining William.
Download The Latest Agenda